Medical students advance vaccination, clinical skills at mass inoculation site
Students from the Kaiser Permanente Bernard J. Tyson School of Medicine apply new clinical skills to help protect community from COVID-19.
Physicians and cancer patients embrace virtual care in a pandemic
Enabled by virtual visits, case conferences and treatment tools, the COVID-19 pandemic has sped up the digital transformation of cancer care at Kaiser Permanente.
Vaccine Equity Toolkit designed to help address equitable access
As vaccines bring hope to end the pandemic, Kaiser Permanente’s toolkit offers approaches to enhance equitable vaccine administration for communities hit hardest by COVID-19.
Turning COVID-19 vaccine hesitancy into vaccine confidence
Paul Thottingal, MD, national infectious disease leader at Kaiser Permanente, shares 5 ways to talk to patients about getting vaccinated when it’s their turn.
Historical mistreatment of African Americans at the root of vaccine hesitancy
American medicine has a history of failing African Americans, notably the Tuskegee experiment and case of Henrietta Lacks; physicians must understand black mistrust to help turn COVID-19 vaccine hesitancy into vaccine confidence.
Analysis confirms racial disparities in COVID-19 infection
Kaiser Permanente study examines race, ethnicity, and risk of infection, hospitalization, and death.
Doctors’ expertise helps steward COVID vaccines
Permanente physicians are sharing their expertise to help guide the fair and equitable distribution of COVID-19 vaccines to Kaiser Permanente members, employees, and the community.
Reflecting on the history of vaccines at a historic moment
Peter Barkett, MD, an internist with Washington Permanente Medical Group, examines the history of vaccines and how they are powerful tools to promote public health.
From the front lines: COVID video diaries
Family medicine physician Alex McDonald, MD, shares the reality of the pandemic on social media.
Kaiser Permanente data key to nation’s COVID-19 vaccine surveillance strategy
Our Vaccine Study Center will lead an effort in searching medical records for serious reactions among patients who receive the vaccine.